MedTrace Logo

Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.

NCT02968979 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 539

Last updated 2019-09-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the frequency of cachexia and the management of cachexia and associated symptoms in a patient population with non-small cell lung cancer (NSCLC).

Conditions

Sponsors & Collaborators

  • French College of General Hospital Pneumologists (CPHG)

    collaborator OTHER

  • French-Speaking Association of Supportive Care in Cancer (AFSOS)

    collaborator UNKNOWN

  • ITEC Services

    collaborator OTHER

  • Chugai Pharma France

    lead INDUSTRY

Principal Investigators

  • Luz Bobadilla, MD · Chugai Pharma France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02968979 on ClinicalTrials.gov